Enzene Introduces NeX™ Suite for Local Biomanufacturing
Enzene has launched NeX™, a comprehensive partnership model designed to enable cost-efficient, high-yielding local biomanufacturing for governments, institutions, and biopharma.
Enzene announced the launch of NeX™, an end-to-end partnership model aimed at facilitating local biomanufacturing capabilities globally. The initiative is designed to support governments, academic institutions, and biopharmaceutical companies in developing and scaling production of biological drugs and other biotechnology products.
The NeX™ model provides access to Enzene's technology, expertise, and infrastructure, with the goal of accelerating the transition from product development to commercial manufacturing. This approach seeks to reduce reliance on complex global supply chains and improve access to critical medicines.
The suite of solutions covers the entire manufacturing process, from initial development and validation through to large-scale production and market release. Enzene stated that the program aims to make biomanufacturing more accessible and economically viable in diverse regions.
Previously operating as a Contract Development and Manufacturing Organization (CDMO), Enzene's introduction of NeX™ represents an expansion of its service offerings to bolster the global biotechnology sector.